Winton Group LTD Catalyst Pharmaceuticals, Inc. Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

A detailed history of Winton Group LTD transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Winton Group LTD holds 59,269 shares of CPRX stock, worth $1.22 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

59,269

Previous 64,395 7.96%

Holding current value

$1.22 Million

Previous $997,000 18.15%

% of portfolio

0.09%

Previous 0.07%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$15.19 - $21.35 $77,863 - $109,440	-5,126 Reduced 7.96%	59,269 $1.18 Million
Q2 2024 Aug 09, 2024	BUY	$14.68 - $16.92 $1,614 - $1,861	110 Added 0.17%	64,395 $997,000
Q1 2024 May 14, 2024	BUY	$13.18 - $17.11 $847,276 - $1.1 Million	64,285 New	64,285 $1.02 Million
Q1 2023 May 12, 2023	BUY	$14.34 - $21.05 $80,260 - $117,816	5,597 Added 38.44%	20,158 $334,000
Q4 2022 Feb 14, 2023	SELL	$12.25 - $19.5 $109,551 - $174,388	-8,943 Reduced 38.05%	14,561 $270,000
Q3 2022 Nov 10, 2022	BUY	$7.06 - $15.52 $165,938 - $364,782	23,504 New	23,504 $302,000
Q4 2021 Feb 10, 2022	SELL	$5.21 - $7.45 $742,576 - $1.06 Million	-142,529 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$4.85 - $6.04 $25,768 - $32,090	5,313 Added 3.87%	142,529 $755,000
Q2 2021 Aug 10, 2021	BUY	$4.29 - $6.05 $63,479 - $89,521	14,797 Added 12.09%	137,216 $789,000
Q1 2021 Jul 21, 2021	BUY	$3.45 - $4.69 $126,080 - $171,396	36,545 Added 42.56%	122,419 $564,000
Q4 2020 Feb 12, 2021	BUY	$2.97 - $3.83 $79,120 - $102,031	26,640 Added 44.97%	85,874 $287,000
Q3 2020 Oct 30, 2020	BUY	$2.97 - $5.08 $175,924 - $300,908	59,234 New	59,234 $176,000
Q2 2019 Jul 08, 2019	SELL	$2.7 - $6.11 $33,625 - $76,093	-12,454 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$2.11 - $5.33 $26,277 - $66,379	12,454 New	12,454 $64,000

Others Institutions Holding CPRX

# of Institutions

326

Shares Held

94.6M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account